08:48 AM EDT, 07/30/2025 (MT Newswires) -- Wave Life Sciences ( WVE ) reported a Q2 net loss Wednesday of $0.31 per diluted share, wider than its net loss of $0.25 per diluted share a year earlier.

Analysts polled by FactSet expected a loss of $0.27 per share.

Revenue for the quarter ended June 30 was $8.7 million, down from $19.7 million a year earlier.

Analysts surveyed by FactSet expected $13.2 million

Shares of the company were up nearly 3% in recent Wednesday premarket activity.